Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

French National Authority for Health (HAS) published new set of decisions by CNEDiMTS about add-on and medical aid reimbursement in June

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS).

Three decisions were released for coronary stents:

  • ULTIMASTER, drug-eluting coronary stent (request for amendment, approved)
  • RESOLUTE ONYX, drug-eluting coronary stent (request for amendment, approved)
  • BIOSS LIM C, drug-eluting bifurcation coronary stent (application for registration, approved)

Two decisions were published for portable oxygen concentrators:

  • ZEN-O RS-00500, portable oxygen concentrator (application for registration, approved)
  • XPO2, portable oxygen concentrator (application for renewal of registration, approved)

Three other decisions:

  • UROLIFT, intra-prostatic implant (application for registration, approved)
  • AXIUM, non-rechargeable implantable system for spinal ganglion stimulation (application for registration, approved)
  • Insulin pumps  (request for amendment of technical specifications, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.